DiaMedica Therapeutics Cash Flow Statement (2018-2019) | DMAC

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019
Operating Activities
Net Income -0.65M-1.74M-1.39M-1.96M-3.25M-2.47M-2.45M-2.48M
Depreciation and Depletion 0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation 0.15M0.29M0.11M0.07M0.13M0.18M0.45M0.40M
Gains from Investment Securities 0.04M0.07M0.00M0.00M0.00M0.07M
Non-cash Items 1.40M0.46M
Cash from Operations -0.94M-1.02M-1.84M-1.90M-3.13M-2.87M-1.23M-1.86M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables 0.71M-0.47M0.72M-0.26M0.15M0.18M-0.45M0.16M
Change in Account Payables -0.03M-0.03M-0.20M0.23M0.20M-0.42M0.05M-0.13M
Change in Accured Expenses 0.24M0.04M0.41M-0.30M-0.13M-0.07M0.20M0.23M
Other Working Capital Changes -0.01M0.06M0.05M0.21M-0.07M-0.10M-0.11M-0.04M
Investing Activities
Capital Expenditures 0.03M0.01M0.02M-0.01M0.01M
Sales of Property, Plant and Equipment 0.00M
Change in Acquisitions & Divestments 3.00M3.00M
Cash from Investing Activities -0.03M-0.01M-0.02M0.01M-10.93M3.01M3.00M1.01M
Financing Activities
Cash from Financing Activities 6.32M0.05M0.03M14.81M-0.00M0.07M-0.00M-0.00M
Additional items
Change in Cash 5.36M-0.98M-1.83M12.93M-14.06M0.21M1.77M-0.86M
Beginning Cash Balance 1.35M6.71M5.73M3.90M16.82M2.76M2.97M0.86M
Free Cash Flow -0.97M-1.03M-1.86M-1.89M-3.13M-2.87M-1.23M-1.88M
Net Cash Flow 5.36M-0.98M-1.83M12.93M-14.06M0.21M1.77M-0.86M